Mar. 17, 2006 – Nanomix Inc., a nanotechnology company commercializing detection applications, announced it has signed a collaboration agreement with researchers at the University of California Berkeley to develop a novel electronic nose diagnostic device.

Nanomix said the agreement would enable it to leverage its proprietary Sensation detection platform and further enhance its product development portfolio in point-of-care detection applications. It involves joint development of a device for clinical diagnosis of disease directly in the physician’s office or outpatient clinic.

Point-of-care diagnosis with an electronic olfactory sensor system based on a detection array could provide multiple advantages versus traditional lab-based techniques in terms of speed, convenience, cost, and improved patient outcomes.